Success Metrics

Clinical Success Rate
100.0%

Based on 14 completed trials

Completion Rate
100%(14/14)
Active Trials
1(6%)
Results Posted
36%(5 trials)

Phase Distribution

Ph phase_2
10
63%
Ph phase_1
3
19%
Ph not_applicable
1
6%
Ph phase_3
2
13%

Phase Distribution

3

Early Stage

10

Mid Stage

2

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
3(18.8%)
Phase 2Efficacy & side effects
10(62.5%)
Phase 3Large-scale testing
2(12.5%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

14 of 14 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(14)
Other(1)

Detailed Status

Completed14
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (18.8%)
Phase 210 (62.5%)
Phase 32 (12.5%)
N/A1 (6.3%)

Trials by Status

completed1488%
unknown16%
active_not_recruiting16%

Recent Activity

1 active trials
Showing 5 of 16
completedphase_3

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

NCT06135415
completedphase_3

A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

NCT07185282
completedphase_1

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

NCT07182864
active_not_recruitingphase_2

Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo

NCT07181187
completedphase_1

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris

NCT01297166
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06135415Phase 3

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

Completed
NCT07185282Phase 3

A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

Completed
NCT07182864Phase 1

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

Completed
NCT07181187Phase 2

Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo

Active Not Recruiting
NCT01297166Phase 1

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris

Completed
NCT05375955Phase 2

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Completed
NCT04088318Phase 2

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Unknown
NCT04664153Phase 2

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Completed
NCT04091087Phase 2

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Completed
NCT02068352Phase 2

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Completed
NCT01449591Phase 2

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

Completed
NCT04704245Not Applicable

Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines

Completed
NCT03004846Phase 1

A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

Completed
NCT02950922Phase 2

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Completed
NCT03394677Phase 2

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Completed
NCT00882245Phase 2

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

Completed

All 16 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
16